Regeneron's antibody drug added to UK Recovery trial of COVID treatments - Reuters UK

4:58am PDT - September 14th, 2020    hydroxychloroquine - Reuters

The world's largest randomised trial of potential medicines for COVID-19 is to add Regeneron's experimental antiviral antibody cocktail REGN-COV2 to the drugs it is testing in patients hospitalised with the disease.